U.S. markets closed
  • S&P 500

    3,585.62
    -54.85 (-1.51%)
     
  • Dow 30

    28,725.51
    -500.10 (-1.71%)
     
  • Nasdaq

    10,575.62
    -161.89 (-1.51%)
     
  • Russell 2000

    1,664.72
    -10.21 (-0.61%)
     
  • Crude Oil

    79.74
    -1.49 (-1.83%)
     
  • Gold

    1,668.30
    -0.30 (-0.02%)
     
  • Silver

    19.01
    +0.30 (+1.62%)
     
  • EUR/USD

    0.9801
    -0.0018 (-0.19%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • GBP/USD

    1.1166
    +0.0043 (+0.38%)
     
  • USD/JPY

    144.7200
    +0.2770 (+0.19%)
     
  • BTC-USD

    19,339.16
    -732.37 (-3.65%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

nCino Analysts Cheer Q2 Beat Amid Uncertain Macros

·3 min read
  • nCino, Inc (NASDAQ: NCNOreported Q2 revenues of $99.6 million, up 50% Y/Y, beating the consensus. Adjusted EPS loss of $(0.04) surpassed the consensus.

  • KeyBanc analyst Josh Beck maintained an Overweight and lowered the price target from $40 to $35.

  • nCino reported solid results similar to the adjusted prior-quarter result driven by a potent mix of go-lives, renewals, upsells, and new logos.

  • SimpleNexus results came in strong despite the challenging mortgage market.

  • It signed Rabobank, the world's leading specialist food and agribusiness bank.

  • Additionally, there was momentum with products like nIQ.

  • The price target reflects rising bank IT budget macro-driven growth risks though he remains Overweight on product leadership and LT cloud banking growth opportunities.

  • Piper Sandler analyst Brent Bracelin maintained an Overweight and raised the price target from $40 to $42.

  • The cross-sell of SimpleNexus (47% Y/Y organic growth) during Q2, and the largest Automated Spreading deal to date at Rabobank contributed to another solid quarter.

  • Q2 revenue beat Street estimates on 29% Y/Y organic subscription growth.

  • He was encouraged by the 2H organic growth outlook of 25% and internal belt-tightening.

  • Tailwinds tied to the inherent automation benefits of implementing an end-to-end Bank OS platform streamlining banking operations appear to partially offset some of the FX and macro headwinds.

  • He raised estimates slightly, increasing the price target on higher estimates and new product wins.

  • Needham analyst Mayank Tandon reiterated a Buy with a price target of $42.

  • NCNO continued its strong momentum in Q2, beating expectations across the board.

  • RPO rose a healthy 28% Y/Y (19% Y/Y organically) on the back of strength in renewals, cross-selling success, and new customer additions, which included signing Rabobank Australia and New Zealand to implement NCNO's automated spreading solution.

  • Management also guided Q3 above consensus and raised its guidance for FY23 despite the macro uncertainty.

  • In addition, NCNO reiterated its plan to be profitable and FCF positive in FY24.

  • Following another impressive beat and raise performance, he remains positive on the shares given the strength in demand for NCNO's market-leading digital banking solutions.

  • Raymond James analyst Alexander Sklar maintained Market Perform following Q2 beat, with an increased outlook for FY23 despite challenging macro and high FX headwinds.

  • While the more challenging macro management adversely impacted net new business measures like RPO/billings, it was still able to deliver some impressive recent wins, including an nIQ entry at a large FI.

  • Management also delivered significant improvements in the margin profile for FY23, with productivity improvements expected to help mitigate the potential impact on growth.

  • Price Action: NCNO shares traded higher by 6.13% at $31.16 on the last check Friday.

Latest Ratings for NCNO

Date

Firm

Action

From

To

Jan 2022

Keybanc

Maintains

Overweight

Jan 2022

Piper Sandler

Maintains

Overweight

Jan 2022

Barclays

Maintains

Equal-Weight

View More Analyst Ratings for NCNO

View the Latest Analyst Ratings

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.